In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Standard Sections: Use clear headings like ‘Work Experience,’ ‘Education,’ and ‘Skills.’ List your most recent job first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback